Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,294.50 -12.67 -0.08%
S&P 500 1,650.51 -4.84 -0.29%
Nasdaq 3,459.42 -3.88 -0.11%
Ticker Volume Price Price Delta
STOXX 50 2,776.78 -58.23 -2.05%
FTSE 100 6,696.79 -143.48 -2.10%
DAX 8,351.98 -178.91 -2.10%
Ticker Volume Price Price Delta
Nikkei 14,484.00 -1,143.28 -7.32%
Hang Seng 22,669.70 -591.40 -2.54%
S&P/ASX 200 5,069.90 +7.45 0.15%
  • Exchange: Xetra
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Drugs

Stada Arzneimittel AG

+ Add to Watchlist

SAZ:GR

33.780 EUR 0.305 0.89%

As of 13:55:02 ET on 05/23/2013.

Company Profile for Stada Arzneimittel AG (SAZ)

Stada Arzneimittel AG manufactures pharmaceuticals. The Company produces generics (products whose patents have expired), brand-name products, and cancer therapy and other special pharmaceuticals. Stada avoids cost-intensive research on active ingredients and concentrates on multi-source products. The Company markets its products worldwide.

Contact Information

Stada Arzneimittel AG

Stadastrasse 2-18
Bad Vilbel, 61118
Germany
Phone: 49-6101-603-0
Fax: 49-6101-603-259

Key Executives for Stada Arzneimittel AG (SAZ)

Hartmut RetzlaffChairman-Mgmt BoardHelmut KraftCFO/Member-Mgmt Board
Axel MuellerChief Production & Dev Ofcr

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil